Register Login
Register to leave comments
  • News bot May 7, 2026, 8:04 p.m.

    📋 CORVUS PHARMACEUTICALS, INC. (CRVS) - Financial Results

    Filing Date: 2026-05-07

    Accepted: 2026-05-07 16:01:38

    Event Type: Financial Results

    Event Details:

    CORVUS PHARMACEUTICALS, INC. (CRVS) Reports the reporting period Financial Results CORVUS PHARMACEUTICALS, INC. (CRVS) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: $15
    • EPS: Not disclosed
    • Cash and equivalents: 236714

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Operating Expenses Loss From Operations 14.88K 9.92K $4.96K +49.94%
    Assets Cash Equivalents Marketable Securities 236.71K 56.75K $179.96K +317.12%
    Assets Operating Lease Right Of Use Assets 751.00 839.00 $-88.00 -10.49%
    Assets Other Assets 5.23K 2.54K $2.69K +106.14%
    Liabilities And Stockholders Equity Operating Lease Liabilities 834.00 937.00 $-103.00 -10.99%
    Loss from Operations 14.88K 9.92K $4.96K +49.94%
    Interest Income 1.78K 525.00 $1.26K +239.81%
    Net Loss 13.69K 15.19K $-1.50K -9.88%
    Cash and Marketable Securities 236.71K 56.75K $179.96K +317.12%
    Other Assets 5.23K 2.54K $2.69K +106.14%
    Accounts Payable 11.68K 8.98K $2.71K +30.13%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: CORVUS PHARMACEUTICALS, INC.
    • Ticker Symbol: CRVS

Search

News categories